185 related articles for article (PubMed ID: 25397683)
21. Recent advances in understanding myelofibrosis and essential thrombocythemia.
Vainchenker W; Constantinescu SN; Plo I
F1000Res; 2016; 5():. PubMed ID: 27134742
[TBL] [Abstract][Full Text] [Related]
22. The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype.
Larsen TS; Pallisgaard N; Møller MB; Hasselbalch HC
Eur J Haematol; 2007 Dec; 79(6):508-15. PubMed ID: 17961178
[TBL] [Abstract][Full Text] [Related]
23. Correlation Between Nuclear Factor E2-Related Factor 2 Expression and Gastric Cancer Progression.
Zheng H; Nong Z; Lu G
Med Sci Monit; 2015 Sep; 21():2893-9. PubMed ID: 26410168
[TBL] [Abstract][Full Text] [Related]
24. Small RNA Sequencing Uncovers New miRNAs and moRNAs Differentially Expressed in Normal and Primary Myelofibrosis CD34+ Cells.
Guglielmelli P; Bisognin A; Saccoman C; Mannarelli C; Coppe A; Vannucchi AM; Bortoluzzi S
PLoS One; 2015; 10(10):e0140445. PubMed ID: 26468945
[TBL] [Abstract][Full Text] [Related]
25. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
26. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
[TBL] [Abstract][Full Text] [Related]
27. Role of nuclear factor erythroid 2-related factor 2 in the oxidative stress-dependent hypertension associated with the depletion of DJ-1.
Cuevas S; Yang Y; Konkalmatt P; Asico LD; Feranil J; Jones J; Villar VA; Armando I; Jose PA
Hypertension; 2015 Jun; 65(6):1251-7. PubMed ID: 25895590
[TBL] [Abstract][Full Text] [Related]
28. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Iványi JL; Marton E; Plander M
Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
[TBL] [Abstract][Full Text] [Related]
29. A formulated red ginseng extract rescues PC12 cells from PCB-induced oxidative cell death through Nrf2-mediated upregulation of heme oxygenase-1 and glutamate cysteine ligase.
Park SH; Jang JH; Chen CY; Na HK; Surh YJ
Toxicology; 2010 Nov; 278(1):131-9. PubMed ID: 20399244
[TBL] [Abstract][Full Text] [Related]
30. HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells.
Malec V; Gottschald OR; Li S; Rose F; Seeger W; Hänze J
Free Radic Biol Med; 2010 Jun; 48(12):1626-35. PubMed ID: 20347035
[TBL] [Abstract][Full Text] [Related]
31. The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms.
Bjørn ME; Hasselbalch HC
Mediators Inflamm; 2015; 2015():648090. PubMed ID: 26538833
[TBL] [Abstract][Full Text] [Related]
32. Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation.
Zhang HS; Li HY; Zhou Y; Wu MR; Zhou HS
Free Radic Biol Med; 2009 Aug; 47(3):261-8. PubMed ID: 19409485
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of apoptosis-related genes from death receptor pathway in chronic myeloproliferative diseases.
Tognon R; Gasparotto EP; Leroy JM; Oliveira GL; Neves RP; Carrara Rde C; Kashima S; Covas DT; Santana M; Souto EX; Zanichelli MA; Velano CE; Simões BP; Alberto FL; Miyashiro K; de Souza AM; Amarante-Mendes GP; de Castro FA
J Clin Pathol; 2011 Jan; 64(1):75-82. PubMed ID: 21045235
[TBL] [Abstract][Full Text] [Related]
34. [Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
Schwarz J; Penka M; Campr V; Pospísilová D; Kren L; Nováková L; Bodzásová C; Brychtová Y; Cerná O; Dulícek P; Joniásová A; Kissová J; Korístek Z; Schützová M; Vonke I; Walterová L
Vnitr Lek; 2011 Feb; 57(2):189-213. PubMed ID: 21416861
[TBL] [Abstract][Full Text] [Related]
35. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
Ashino T; Yamamoto M; Yoshida T; Numazawa S
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations.
Boveri E; Passamonti F; Rumi E; Pietra D; Elena C; Arcaini L; Pascutto C; Castello A; Cazzola M; Magrini U; Lazzarino M
Br J Haematol; 2008 Jan; 140(2):162-8. PubMed ID: 18028479
[TBL] [Abstract][Full Text] [Related]
37. Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions.
van Horssen J; Drexhage JA; Flor T; Gerritsen W; van der Valk P; de Vries HE
Free Radic Biol Med; 2010 Nov; 49(8):1283-9. PubMed ID: 20673799
[TBL] [Abstract][Full Text] [Related]
38. Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases.
Dentali F; Ageno W; Rumi E; Casetti I; Poli D; Scoditti U; Maffioli M; di Minno MN; Caramazza D; Pietra D; De Stefano V; Passamonti F
Thromb Res; 2014 Jul; 134(1):41-3. PubMed ID: 24787989
[TBL] [Abstract][Full Text] [Related]
39. [CXCR4 and Nrf2 expressions in non-small cell lung cancer and their clinical implications].
Hu T; Yao Y; Yu S; Guo H; Tian T; Han L; Wang W; Guo Q; Wang J; Nan K; Wang S
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):153-8. PubMed ID: 24589587
[TBL] [Abstract][Full Text] [Related]
40. Simvastatin inhibits oxidative stress via the activation of nuclear factor erythroid 2-related factor 2 signaling in trophoblast cells.
Chigusa Y; Kawasaki K; Kondoh E; Mogami H; Ujita M; Fujita K; Tatsumi K; Takeda S; Konishi I
J Obstet Gynaecol Res; 2016 Jan; 42(1):36-43. PubMed ID: 26556031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
